Drug Approval | July 02, 2022
Ascentage Pharma gets IND clearance by the US FDA for novel EED Inhibitor APG-5918
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
Brings 25 years of global operations and supply chain experience to Piramal
Bringing next-gen cannabinoid therapeutics to cancer patients
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Subscribe To Our Newsletter & Stay Updated
